Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients

被引:16
作者
Hess, Aaron S. [1 ]
Kleinberg, Michael [2 ]
Sorkin, John D. [3 ,4 ]
Netzer, Giora [1 ,5 ]
Johnson, Jennifer K. [6 ]
Shardell, Michelle [1 ]
Thom, Kerri A. [1 ]
Harris, Anthony D. [1 ]
Roghmann, Mary-Claire [1 ,2 ]
机构
[1] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
[2] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Baltimore VA Med Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Div Gerontol & Geriatr Med, Baltimore, MD 21201 USA
[5] Univ Maryland, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA
[6] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
Antimicrobial resistance; Surveillance cultures; Neutropenic fever; BLOOD-STREAM INFECTIONS; STEM-CELL TRANSPLANT; INADEQUATE ANTIMICROBIAL TREATMENT; NEUTROPENIC PATIENTS; BACTERIAL TRANSLOCATION; MORTALITY; SURVEILLANCE; OUTCOMES; BACILLI; PREDICTION;
D O I
10.1016/j.diagmicrobio.2014.01.022
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We hypothesized that prior colonization with antibiotic-resistant Gram-negative bacteria is associated with increased risk of subsequent antibiotic-resistant Gram-negative bacteremia among cancer patients. We performed a matched case-control study. Cases were cancer patients with a blood culture positive for antibiotic-resistant Gram-negative bacteria. Controls were cancer patients with a blood culture not positive for antibiotic-resistant Gram-negative bacteria. Prior colonization was defined as any antibiotic-resistant Gram-negative bacteria in surveillance or non-sterile-site cultures obtained 2-365 days before the bacteremia. Thirty-two (37%) of 86 cases and 27 (8%) of 323 matched controls were previously colonized by any antibiotic-resistant Gram-negative bacteria. Prior colonization was strongly associated with antibiotic-resistant Gram-negative bacteremia (odds ratio [OR] 7.2, 95% confidence interval [CI] 3.5-14.7) after controlling for recent treatment with piperacillin-tazobactam (OR 2.5, 95% CI 1.3-4.8). In these patients with suspected bacteremia, prior cultures may predict increased risk of antibiotic-resistant Gram-negative bacteremia. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:73 / 76
页数:4
相关论文
共 27 条
  • [1] [Anonymous], 2011, Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement
  • [2] PREDICTION BY SURVEILLANCE CULTURES OF BACTEREMIA AMONG NEUTROPENIC PATIENTS TREATED IN A PROTECTIVE ENVIRONMENT
    COHEN, ML
    MURPHY, MT
    COUNTS, GW
    BUCKNER, CD
    CLIFT, RA
    MEYERS, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) : 789 - 793
  • [3] The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs
    Cosgrove, SE
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 : S82 - S89
  • [4] Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073
  • [5] Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients
    Garnica, M.
    Maiolino, A.
    Nucci, M.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (03) : 289 - 293
  • [6] Clinical and economic impact of common multidrug-resistant gram-negative bacilli
    Giske, Christian G.
    Monnet, Dominique L.
    Cars, Otto
    Carmeli, Yehuda
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 813 - 821
  • [7] Antibiotic-resistant Gram-negative Bacteremia in Pediatric Oncology Patients-Risk Factors and Outcomes
    Haeusler, Gabrielle M.
    Mechinaud, Francoise
    Daley, Andrew J.
    Starr, Mike
    Shann, Frank
    Connell, Thomas G.
    Bryant, Penelope A.
    Donath, Susan
    Curtis, Nigel
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (07) : 723 - 726
  • [8] Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    Harbarth, S
    Garbino, J
    Pugin, J
    Romand, JA
    Lew, D
    Pittet, D
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (07) : 529 - 535
  • [9] GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER
    HUGHES, WT
    ARMSTRONG, D
    BODEY, GP
    FELD, R
    MANDELL, GL
    MEYERS, JD
    PIZZO, PA
    SCHIMPFF, SC
    SHENEP, JL
    WADE, JC
    YOUNG, LS
    YOW, MD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) : 381 - 396
  • [10] The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
    Ibrahim, EH
    Sherman, G
    Ward, S
    Fraser, VJ
    Kollef, MH
    [J]. CHEST, 2000, 118 (01) : 146 - 155